Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00315354
Other study ID # 1R01DK072428
Secondary ID R01DK072428
Status Completed
Phase N/A
First received April 14, 2006
Last updated November 22, 2016
Start date April 2006
Est. completion date April 2013

Study information

Verified date November 2016
Source Boston Children’s Hospital
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

The aim of this study is to evaluate the effects of three dominant dietary patterns - conventional low-fat, low-glycemic index (GI) and very-low-carbohydrate - on energy metabolism and heart disease risk factors following weight loss in obese young adults in a feeding study


Description:

For most of the last half century, reduction in fat intake has been the primary nutritional approach for the prevention and treatment of obesity and cardiovascular disease (CVD). Over the last few years, very low carbohydrate (Atkins-type) diets have achieved great popularity, with publication of several studies suggesting greater weight loss and improvements in CVD risk factors over 3 to 6 months. Recently, a third dietary approach focused on glycemic index (GI) has generated interest. However, few studies have compared the effects of these diets on body weight regulation and risk for CVD. The primary hypotheses of this study are that any diet that lowers the postprandial rise in blood glucose (very-low-carbohydrate or low-GI) will have beneficial effects on the physiological adaptations to weight loss and on some CVD risk factors. However, other CVD risk factors will be adversely affected by a very-low-carbohydrate vs. a low-GI diet. Preliminary data provide strong support for these hypotheses, by showing that resting energy expenditure declines less and CVD risk factors improve more with weight loss on a low-glycemic load diet compared to a conventional low-fat diet. This application proposes a cross-over feeding design to study the effects of three diets following 12.5% weight loss in obese young adult subjects (n = 24, age 18 to 40 years). The diets are: 1) conventional low-fat, with 60% carb, 20% fat, 20% protein; 2) low-GI with 40% carb, 40% fat, 20% protein; and 3) very-low-carbohydrate with 10% carb, 60% fat, 30% protein. The primary outcome is resting energy expenditure (indirect calorimetry). Secondary outcomes include total energy expenditure (doubly labeled water), thermic effect of food (indirect calorimetry), physical activity (accelerometry), insulin resistance and B-cell function (frequently-sampled OGTT), blood lipids, blood pressure and measures of systemic inflammation and coagulopathy. This study should have major public health implications to the millions of Americans currently following diets to decrease body weight and risk for heart disease.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date April 2013
Est. primary completion date June 2010
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- BMI = 27 kg/m2

- Willing and able to come to the GCRC 5 days per week to consume a supervised meal and pick-up food for all other meals

- Available for scheduled hospital admissions

- Willing to abstain from alcohol consumption for the duration of the study

- If female, regular menstrual cycles (defined as 26 to 30 days between cycles; no more than one day variation in the duration of menstrual flow)

Exclusion Criteria:

- Weight > 350 lbs

- Change in body weight (± 10%) over preceding year

- Taking any medications or dietary supplements that might affect body weight, appetite, or energy expenditure

- Smoking (1 cigarette in the last week)

- High levels of physical activity

- Currently following a special diet

- Abnormal laboratory screening tests

- Type 2 diabetes mellitus

- Allergies or aversions to foods on the study menu

- Previous diagnosis of an eating disorder or any other mental health disorder

- If female, pregnant in the past 12 months or planning to become pregnant during the study period

- If female, lactating in the preceding 12 months

- If taking birth control medication, change in medication in previous 3 months or plans to change medication during the study period

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Other:
Low glycemic index diet
Feeding protocol, all foods prepared in a metabolic kitchen
Low fat diet
Feeding protocol, all foods prepared in a metabolic kitchen
Very low carbohydrate diet
Feeding protocol, all foods prepared in a metabolic kitchen

Locations

Country Name City State
United States Children's Hospital Boston Boston Massachusetts

Sponsors (3)

Lead Sponsor Collaborator
Boston Children’s Hospital Brigham and Women's Hospital, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

References & Publications (2)

Ebbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL, Garcia-Lago E, Ludwig DS. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA. 2012 Jun 27;307(24):2627-34. doi: 10.1001/jama.2012.6607. — View Citation

Walsh CO, Ebbeling CB, Swain JF, Markowitz RL, Feldman HA, Ludwig DS. Effects of diet composition on postprandial energy availability during weight loss maintenance. PLoS One. 2013;8(3):e58172. doi: 10.1371/journal.pone.0058172. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary resting energy expenditure using indirect calorimetry in the fasting state end of each dietary period No
Primary insulin resistance assessed by frequently-sampled oral glucose tolerance test end of each dietary period No
Primary thyroid function tests end of each dietary period No
Secondary total energy expenditure using doubly labeled water methodology end of each dietary period No
Secondary thermic effect of food using indirect calorimetry end of each dietary period No
Secondary physical activity using accelerometry end of each dietary period No
Secondary serum lipids end of each dietary period No
Secondary plasminogen activator inhibitor-1 end of each dietary period No
Secondary C-reactive protein end of each dietary period No
Secondary blood pressure end of each dietary period No
Secondary hunger/appetite end of each dietary period No
Secondary insulin 30 minutes after oral glucose (as an effect modifier) baseline No
Secondary Core temperature End of each dietary period No
Secondary secreted frizzle-related protein-4 end of each dietary period No
Secondary heme-oxygenase end of each dietary period No
Secondary Irisin end of each dietary period No
Secondary fibroblast growth factor-21 end of each dietary period No
Secondary chemerin end of each dietary period No
Secondary trimethylamine N-oxide fasting and postprandial, end of each dietary period No
Secondary alanine aminotransferase end of each dietary period No
Secondary Uric acid end of each dietary period No
Secondary insulin fasting and postprandial, end of each dietary period No
Secondary ghrelin fasting and postprandial, end of each dietary period No
Secondary gastric inhibitory peptide fasting and postprandial, end of each dietary period No
Secondary GLP1 fasting and postprandial, end of each dietary period No
Secondary PYY fasting and postprandial, end of each dietary period No
Secondary Amylin fasting and postprandial, end of each dietary period No
Secondary Leptin end of each dietary period No
Secondary Metabolomic analysis Evaluate the effect of diet on metabolomic profile in plasma, with the aim of assessing dietary adherence and exploring diet-disease mechanisms end of each dietary period No
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2